Micafungin and Renal impairment - a phase IV clinical study of FDA data

Summary:

Renal impairment is reported as a side effect among people who take Micafungin (micafungin sodium), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Itraconazole, and have Hiv infection.

The phase IV clinical study analyzes which people have Renal impairment when taking Micafungin. It is created by eHealthMe based on reports of 6,557 people who have side effects when taking Micafungin from the FDA, and is updated regularly.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

What is Renal impairment?

Renal impairment (severely reduced kidney function) is found to be associated with 2,209 drugs and 2,471 conditions by eHealthMe. Check the latest studies of Renal impairment.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

6,557 people reported to have side effects when taking Micafungin.
Among them, 163 people (2.49%) have Renal impairment.

Could Micafungin cause Renal impairment?

Among these 163 people:

How long have people been on Micafungin when they have Renal impairment? *

Click here to view more results

What is the gender of people who have Renal impairment when taking Micafungin? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin and have Renal impairment?

- Check whether Renal impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micafungin:

Micafungin (6,562 reports)

Renal impairment treatments and more:

Renal impairment (99,633 reports)

How severe was Renal impairment and when was it recovered:

Renal impairment in Micafungin

Expand to all the drugs that have ingredients of micafungin sodium:

Renal impairment and drugs with ingredients of micafungin sodium (175 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micafungin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Renal impairment:

Renal impairment (2,209 drugs)

Browse all the conditions that are associated with Renal impairment:

Renal impairment (2,471 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on micafungin sodium (the active ingredients of Micafungin) and Micafungin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.